- HuaChanSu suppresses the growth of hepatocellular carcinoma cells by interfering with pentose phosphate pathway through down-regulation of G6PD enzyme activity and expression
Qi Wu et al, 2024, Heliyon CrossRef - Bufalin inhibits human diffuse large B-cell lymphoma tumorigenesis by inducing cell death through the Ca2+/NFATC1/cMYC pathway
Jincheng Song et al, 2021, Carcinogenesis CrossRef - Metabolites from Bufo gargarizans (Cantor, 1842): A review of traditional uses, pharmacological activity, toxicity and quality control
Xiang Zhan et al, 2020, Journal of Ethnopharmacology CrossRef - Mistletoe extract Fraxini inhibits the proliferation of liver cancer by down-regulating c-Myc expression
Peiying Yang et al, 2019, Scientific Reports CrossRef - Overexpression of the SMYD3 Promotes Proliferation, Migration, and Invasion of Pancreatic Cancer
Cheng-lin Zhu et al, 2020, Digestive Diseases and Sciences CrossRef - New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin
Chien-shan Cheng et al, 2019, Cancer Cell International CrossRef - Chemical Composition, Pharmacological Effects and Clinical Applications of Cinobufacini
Qian Zuo et al, 2024, Chinese Journal of Integrative Medicine CrossRef - The Development of Toad Toxins as Potential Therapeutic Agents
Ji Qi et al, 2018, Toxins CrossRef - Meta-Analysis of Therapy of Cinobufacini Capsule Adjunct with First-Line Platinum-Based Chemotherapy for the Treatment of Advanced NSCLC
Wenpan Peng et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef - Identification of potential anti-tumor targets and mechanisms of HuaChanSu injection using network pharmacology and cytological experiments in Breast cancer
Zetian Yang et al, 2024, PLOS ONE CrossRef - Huachansu Capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway
Tengyang Ni et al, 2019, Biomedicine & Pharmacotherapy CrossRef